Company Overview and News

 
Vijaya Bank defers capital raising plan for FY#39;19

2018-05-21 moneycontrol
Vijaya Bank today said its board has deferred the capital raising plan under Basel-III for 2018-19 fiscal.

 
Vijaya Bank defers fundraising plan for 2018-19

2018-05-20 livemint
Mumbai: Public sector bank Vijaya Bank on Sunday said that its board has deferred a fund-raising plan for 2018-19. On 17 May, the bank had informed exchanges that its board will meet on 20 May to discuss a proposed capital-raising plan under Basel III.

 
Vijaya Bank - Outcome of Board Meeting

2018-05-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Vijaya Bank - Strikes/Lockouts/Disturbances

2018-05-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
COMMENT-Public sector bank results show reform is the only way forward

2018-05-18 moneycontrol
Public sector (PSU) banks, barring a handful, have not been on the radar of the investor community for a while. After the latest quarterly report, hopes of a revival have now turned into a distant dream. Not only are the reported numbers weighed down by burden of bad asset provisions, the core performance is weakening incrementally in every quarter. Looking at the magnitude of the losses, the much-talked-about capital infusion by the government appears grossly inadequate.

 
Vijaya Bank - Updates

2018-05-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Reliance Naval designated as a non-performing asset

2018-05-15 janes
Mumbai-based Reliance Naval and Engineering Limited (RNEL) has been designated by the state-owned Vijaya Bank as a ‘non-performing asset’ sending the shipbuilder’s share price to a record low.

 
Nifty ends rangebound session flat on caution ahead of Karnataka election results

2018-05-14 moneycontrol
Benchmark indices ended the rangebound session on a flat note Monday as caution prevailed ahead of Karnataka election results due tomorrow.

 
Closing Bell: Sensex, Nifty end flat as traders await Karnataka election results

2018-05-14 moneycontrol
Market Closing: The market ended flat as traders maintained cautious stance ahead of Karnataka election results due tomorrow.

 
Vijaya Bank - Reply to Clarification Sought

2018-05-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Vijaya Bank - Clarification

2018-05-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Vijaya Bank will grow net profit by 5 times in FY19, says CEO Sankara Narayanan

2018-05-09 moneycontrol
Vijaya Bank, one of the smallest public sector lenders, hopes to grow its net profit by five times to over Rs 1,000 crore by the end of this financial year ending March 2019.

 
Vijaya Bank - Appointment

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Strong dollar, oil keep rupee under pressure

2018-05-07 thehindubusinessline
The Indian rupee is continuing to get beaten down. Though the currency opened the truncated week on a positive note, it failed to retain the momentum. It made a high of 66.52 but failed to sustain higher.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

14h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

14h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...